Does Rallies show 13F holders for NEPH?

Yes. Rallies tracks hedge fund and 13F ownership data for NEPH, including fund names, share counts, latest tracked quarter, and position changes when available.

Is NEPH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for NEPH. It does not provide personalized investment advice.

NEPH (Nephros Inc.) Stock Analysis - Hedge Fund Holdings

Nephros Inc. (NEPH) is a publicly traded Healthcare sector company. As of May 21, 2026, NEPH trades at $3.57 with a market cap of $39.95M and a P/E ratio of 32.64. NEPH moved -2.34% today. Year to date, NEPH is -26.65%; over the trailing twelve months it is +54.68%. Its 52-week range spans $1.36 to $6.42. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces NEPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns NEPH stock?

Hedge funds tracked by Rallies that own NEPH include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nephros Inc..

NEPH Key Metrics

Key financial metrics for NEPH
Metric	Value
Price	$3.57
Market Cap	$39.95M
P/E Ratio	32.64
EPS	$0.11
Dividend Yield	0.00%
52-Week High	$6.42
52-Week Low	$1.36
Volume	0
Avg Volume	0
Revenue (TTM)	$18.79M
Net Income	$1.19M
Gross Margin	61.87%

Top Hedge Funds Holding NEPH

Renaissance Technologies holds 24.44K shares of NEPH, changed -40.38% as of Sep 30, 2024.
Citadel Advisors holds 14.29K shares of NEPH, changed -17.10% as of Dec 31, 2024.

Latest NEPH News

Nephros Targets $25M New York Market with New Regional Sales Leader — Apr 16, 2026
Nephros Launches Chargeable Water Management Programs After ASSE 12080 Certification — Apr 1, 2026
Nephros Q4 Net Income Drops 67% as Gross Margin Falls to 58% — Mar 14, 2026

Recent NEPH Insider Trades

Amron Arthur H bought 3.00K (~$6.73K) on May 30, 2024.
Amron Arthur H bought 2.00K (~$4.44K) on May 28, 2024.
Banks Robert R. Jr. bought 50.00K (~$112.05K) on May 16, 2024.

NEPH Analyst Consensus

1 analysts cover NEPH: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.

Common questions about NEPH

Who owns NEPH stock?: Hedge funds tracked by Rallies that own NEPH include Renaissance Technologies and Citadel Advisors. The latest tracked quarter is Sep 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Nephros Inc..
Does Rallies show 13F holders for NEPH?: Yes. Rallies tracks hedge fund and 13F ownership data for NEPH, including fund names, share counts, latest tracked quarter, and position changes when available.
Is NEPH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for NEPH. It does not provide personalized investment advice.